Overview

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

Status:
Completed
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether infliximab is effective on fat-free mass in the treatment of patients with moderate to severe COPD suffering from cachexia.
Phase:
Phase 2
Details
Lead Sponsor:
Center for Integrated Rehabilitation and Organ Failure Horn
Collaborator:
Centocor, Inc.
Treatments:
Infliximab